Dorcet G, Migne H, Biotti D, Bost C, et al. Early B cells repopulation in multiple sclerosis patients treated with rituximab is not predictive of a risk of relapse or clinical progression. J Neurol 2022 Jun 2. pii: 10.1007/s00415-022-11197.
PMID: 35652942